Papers

4

Total Citations

58

H-Index

4

About

Fady Baky is a urologic surgeon and researcher whose work centers on minimally invasive and robotic surgical techniques for urological malignancies, with a particular focus on testicular cancer and bladder cancer. He has emerged as a leading voice in advancing robotic retroperitoneal lymph node dissection (RPLND) for testicular cancer, contributing foundational evidence on both its safety and oncological efficacy. His 2022 retrospective cohort study on minimally invasive retroperitoneal lymph node dissection, his most cited work with 27 citations, helped establish the feasibility of this complex procedure in a minimally invasive framework. Building on this, his multicenter collaborative research on robotic post-chemotherapy RPLND — a technically demanding operation historically requiring open surgery — has expanded the evidence base internationally, with a worldwide multicenter study published in 2024 further validating oncological outcomes. Beyond testicular cancer, Baky has investigated perioperative decision-making in robot-assisted radical cystectomy, including the role of ureteral stents during intracorporeal ileal conduit construction. His growing body of collaborative, multi-institutional research reflects a commitment to refining surgical standards and improving patient outcomes across genitourinary oncology.

Research Focus

Key Achievements

4
H-Index
4
Papers
58
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Minimally invasive retroperitoneal lymph node dissection for men with testis cancer: a retrospective cohort study of safety and feasibility
27 citations · 2022
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 62
🏛 Institutions: The University of Texas Southwestern Medical Center, Memorial Sloan Kettering Cancer Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago